PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

Nghiem, Paul T., Bhatia, Shailender, Lipson, Evan J., Kudchadkar, Ragini R., Miller, Natalie J., Annamalai, Lakshmanan, Berry, Sneha, Chartash, Elliot K., Daud, Adil, Fling, Steven P., Friedlander, Philip A., Kluger, Harriet M., Kohrt, Holbrook E., Lundgren, Lisa, Margolin, Kim, Mitchell, Alan, Olencki, Thomas, Pardoll, Drew M., Reddy, Sunil A., Shantha, Erica M., Sharfman, William H., Sharon, Elad, Shemanski, Lynn R., Shinohara, Michi M., Sunshine, Joel C., Taube, Janis M., Thompson, John A., Townson, Steven M., Yearley, Jennifer H., Topalian, Suzanne L., Cheever, Martin A.·2016·New England Journal of Medicine
DOI 10.1056/nejmoa1603702

Cited by (1,000)

Items 801–900 of 1,000

  1. Current and preclinical treatment options for Merkel cell carcinoma
    Büke Celikdemir, Roland Houben, Thibault Kervarrec, Mahtab Samimi, David Schrama · 2023 · Expert Opinion on Biological Therapy
  2. Current Trends and Future Directions of Malignancy After kidney Transplantation: A 1970-2022 Bibliometric Analysis
    Fan Jiang, Fang Wang, Tianyu Zhang, Hongmei Dong, Hongwei Bai, Liping Chen · 2023 · Annals of Transplantation
  3. Personalized treatment concepts in extraocular cancer
    Sitong Ju, Alexander Christopher Rokohl, Yongwei Guo, Ke Yao, Wanlin Fan, Ludwig Maximilian Heindl · 2024 · Advances in Ophthalmology Practice and Research
  4. Patterns of initial distant metastases in 151 patients undergoing surveillance for treated Merkel cell carcinoma
    Emily Kim, Mofei Liu, Anita Giobbie‐Hurder, Furkan Bahar, Karam Khaddour, Ann Willman Silk, Manisha Thakuria · 2024 · Journal of the European Academy of Dermatology and Venereology
  5. Updates on eyelid cancers
    Kristina Joana Schoelles, Claudia Auw‐Haedrich · 2024 · Asia-Pacific Journal of Ophthalmology
  6. Neuroendocrine Neoplasms
    Sukhjeet Kamboj, Francis Guerra-Bauman, Hussain Mahmud, Abdul Waheed · 2024 · Primary Care Clinics in Office Practice
  7. Características clínico-epidemiológicas del carcinoma de células de Merkel en una serie de 38 pacientes
    M. Dañino-García, Javier Jesús Dominguez‐Cruz, Carmen Pérez-Ruiz, Julián Conejo‐Mir, J Rodríguez · 2018 · Actas Dermo-Sifiliográficas
  8. [Prominent ears: a simple ambulatory technique under local anesthetic].
    Jacques Dechamboux, H. Sadek, Burger Raphaël · 2000 · PubMed
  9. Targeting cancer-associated glycans as a therapeutic strategy in leukemia
    Ashraf Abdullah Saad · 2022 · All Life
  10. Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
    Zhiqiang Sun, Hongxiang Jiang, Tengfeng Yan, Gang Deng, Qianxue Chen · 2022 · Cancers
  11. Phospho-STAT5B Expression Is a Prognostic Marker for Merkel Cell Carcinoma
    Taku Fujimura, Sadanori Furudate, YUMI KAMBAYAHSI, Aya Kakizaki, Yuki Yamamoto, Hisako Okuhira, Noriki Fujimoto, Setsuya Aiba · 2017 · Anticancer Research
  12. Merkel cell carcinoma: literature review
    Abdalla Saad Abdalla Al‐Zawi, Andrew Prodromou, Dennis Wayne Chicken, Turhan Comez, Ekin Deniz · 2017 · Nowotwory Journal of Oncology
  13. A case report of recurrent Merkel cell carcinoma with synchronous metastases to the heart and stomach
    Joo Young Ha, Song Ee Park, Hee Sung Kim, Hoyoun Won, Beom Jin Kim, In Gyu Hwang · 2018 · Medicine
  14. Emerging Evidence for Infectious Causes of Cancer in the United States
    Heidi E. Brown, Leslie K. Dennis, Priscilla Lauro, Purva Jain, Erin Pelley, Eyal Oren · 2019 · Epidemiologic Reviews
  15. Targeting the epigenetic addiction of Merkel cell carcinoma
    Federico Mauri, Cédric Blanpain · 2020 · EMBO Molecular Medicine
  16. Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome
    Andrés Chang, Danielle Schlafer, Christopher R. Flowers, Pamela B. Allen · 2017 · Expert Opinion on Investigational Drugs
  17. Molecular and immune targets for Merkel cell carcinoma therapy and prevention
    Leah Cohen, Kenneth Yee Tsai · 2019 · Molecular Carcinogenesis
  18. Safety and Efficacy in Relapsed or Refractory Classic Hodgkin’s Lymphoma Treated with PD-1 Inhibitors: A Meta-Analysis of 9 Prospective Clinical Trials
    Xueyan Zhang, Li Chen, Yawei Zhao, Huiru Yin, He Ma, Miao He · 2019 · BioMed Research International
  19. Merkel Cell Carcinoma Treatment in Finland in 1986–2016—A Real-World Data Study
    Helka Sahi, Jenny Their, Mika Gissler, Virve Koljonen · 2020 · Cancers
  20. CD38 is a good predictor of anti-PD-1 immunotherapy responsiveness in hepatocellular carcinoma
    Siting Goh, Harry Ho Man Ng, Valerie Chew, Xin Ni Sim, Huihua Li, Sherlly Lim, Jeffrey Chun Tatt Lim, Josh Jie Hua Loh, Khin Sabai, Clara Chong Hui Ong et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  21. β Cell replacement: improving on the design.
    Roberto Castro-Gutiérrez, Aaron W. Michels, Holger A. Russ · 2018 · PubMed
  22. Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort
    Sandip Pravin Patel, Jillian Fisher, Young Kwang Chae, Luisa M. Solis Soto, Anup Kasi, Bhavana Konda, Mark Andrew Walshauser, Edwin Roger Parra, J K Zhang, Caroline Duault et al. · 2025 · Journal for ImmunoTherapy of Cancer
  23. Coordinated expression of retained introns and poison exons in renal cell carcinoma
    José C. Martínez, Mi Zhou, Gilbert Giri, Yi‐Hsuan Tsai, Meghan M. Rowley, Grant A. Goda, Maria M. Aleman, William Y. Kim, Daniel José García Domínguez · 2025 · Cell Reports
  24. Merkel Cell Carcinoma Masquerading As Cellulitis: A Case Report and Review of the Literature
    Firas M. Safa, Millie Pant, Chanudi Kashmalee Weerasinghe, R. Felix, T. Terjanian · 2018 · Current Oncology
  25. Response to PD-1 Immunotherapy in Metastatic Spiradenocarcinoma
    Clinton Wu, Melissa Chow, Michelle Temby, Timothy H. McCalmont, ADIL I. DAUD · 2021 · JCO Precision Oncology
  26. Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma
    Karam Khaddour, Alice Yao Zhou, Omar Hameed Butt, Jiayi Huang, George Ansstas · 2023 · Frontiers in Oncology
  27. The Role of Radiation, Immunotherapy, and Chemotherapy in the Management of Locally Advanced or Metastatic Cutaneous Malignancies
    Irini Yacoub, Kareem N. Rayn, Jehee Isabelle Choi, Richard Lorne Bakst, Arpit M. Chhabra, Joshua Y. Qian, Peter A.S. Johnstone, Charles B. Simone · 2024 · Cancers
  28. Promoting macrophage phagocytosis of cancer cells for effective cancer immunotherapy
    Lei Wang, Ziyi Hu, Wencan Zhang, Zhixin Wang, Ming Cao, Xu Cao · 2024 · Biochemical Pharmacology
  29. Merkel Cell Polyomavirus Co-Infection in HIV/AIDS Individuals: Clinical Diagnosis, Consequences and Treatments
    Xianfeng Zhou, Chenxue Yin, Ziqi Lin, Zhangren Yan, Jiangang Wang · 2025 · Pathogens
  30. Late-Onset Myocarditis Following Immune Checkpoint Inhibitors Therapy: A Case Series with Literature Review
    Harun Muğlu, Erdem Sünger, Bahadır Köylü, Didem Tunalı, Cengiz Erol, Fatih Selçukbırıcık, Ahmet Erkan Bilici, Ömer Fatih Ölmez · 2025 · Medicina
  31. Acute Myocarditis and Inflammatory Cardiomyopathies: Insights From Cardiac Magnetic Resonance Findings
    Francesco Lauriero, Carmel Helena Vita, Alessio Perazzolo, Giovanni Sanseverino, Eleonora Moliterno, Giuseppe Rovere, Riccardo Marano, Luigi Natale · 2025 · Echocardiography
  32. Communication pathways bridge local and global conformations in an IgG4 antibody
    Thomas Tarenzi, Marta Rigoli, Raffaello Potestio · 2021 · Scientific Reports
  33. Exposure‐response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy
    Ronald de Wit, Thomas B. Powles, Daniel Castellano, Andrea Necchi, Jae‐Lyun Lee, Michiel S. van der Heijden, Nobuaki Matsubara, Aristotelis Bamias, Aude Fléchon, Cora N. Sternberg et al. · 2022 · British Journal of Clinical Pharmacology
  34. A Review of Immune Checkpoint Blockade for the General Surgeon
    Xavier L. Baldwin, Philip M. Spanheimer, Stephanie Downs‐Canner · 2022 · Journal of Surgical Research
  35. An Effective Primary Treatment Using Radiotherapy in Patients with Eyelid Merkel Cell Carcinoma
    M. Boileau, Manon Dubois, Henry Abi Rached, Alexandre Escande, Xavier Mirabel, Laurent Mortier · 2023 · Current Oncology
  36. Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab
    Alexander Thiem, Hermann Kneitz, Patrick Schummer, S Herz, David Schrama, Roland Houben, Matthias Goebeler, Bastian Schilling, Anja Gesierich · 2017 · Acta Dermato Venereologica
  37. Integrating the Management of Nodal Metastasis Into the Treatment of Nonmelanoma Skin Cancer
    Sue Sun Yom · 2019 · Seminars in Radiation Oncology
  38. Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab
    Anna Kathrin Stüven, Bertram Wiedenmann · 2019 · Oncotarget
  39. Complete response with neoadjuvant avelumab in Merkel cell carcinoma – A case report
    Nadine H. Abdallah, Misako Nagasaka, Tahmida Chowdhury, Kunil K. Raval, Jeffrey M. Hotaling, Ammar W. Sukari · 2019 · Oral Oncology
  40. Mapping the Binding Hot Spots on Human Programmed Cell Death 1 and Its Ligand with Free-Energy Simulations
    Hanjing Ding, Hui Liu · 2019 · Journal of Chemical Information and Modeling
  41. Merkel Cell Carcinoma: A 28‐Year Experience
    Kera L. Kwan, Shabnam Ghazizadeh, Andy S. Moon, Dennis Rünger, Dipti P. Sajed, David A. Elashoff, Maie A. St. John · 2020 · Otolaryngology
  42. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A
    Stefano Guadagni, Antonietta Rosella Farina, Lucia Annamaria Cappabianca, Michela Sebastiano, Rita Maccarone, Veronica Zelli, Marco Clementi, Alessandro Chiominto, Gemma Bruera, Enrico Ricevuto et al. · 2020 · International Journal of Molecular Sciences
  43. Nonmelanoma Skin Cancers
    Yaohui Gloria Xu, Juliet L. Aylward, Andrew M. Swanson, Vladimir S. Spiegelman, Erin R. Vanness, Joyce M. C. Teng, Stephen N. Snow, Gary S. Wood · 2020 · Elsevier eBooks
  44. The Association of Radiation Therapy and Chemotherapy on Overall Survival in Merkel Cell Carcinoma: A Population-Based Analysis
    Aleksander Vayntraub, Nadine Tayeb, Bryan S. Squires, Janice M. Mehnert, Quais N. Hassan, Nikhil Sebastian, Rohan Deryaniyagala, Thomas J. Quinn · 2021 · Cureus
  45. Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity
    Abdulrazzak Zarifa, Juan Lopez‐Mattei, Nicolas L. Palaskas, Cezar Iliescu, Jean‐Bernard Durand, Peter Y. Kim · 2021 · Advances in experimental medicine and biology
  46. Best practices in surgical and nonsurgical management of head and neck Merkel cell carcinoma: An update
    Daniela Duarte‐Bateman, Alan S. Shen, Taylor Bullock, Payam Sadeghi, Joseph M. Escandón, Eliška Dědková, Brian Gastman · 2022 · Molecular Carcinogenesis
  47. Scientifically based combination therapies with immuno‐oncology checkpoint inhibitors
    Hui Yi Chew, Riccardo Dolcetti, Fiona Simpson · 2020 · British Journal of Clinical Pharmacology
  48. Merkel cell carcinoma in solid organ transplant recipients: prognosis and response to immunotherapy
    Tomoko Akaike, Peter Yi Ch’en, Daniel S. Hippe, Macy W Gilmour, Emily Gong, Alex Fu, Neha Singh, Kelsey Cahill, Lindsay Gunnell, Nasreen A. Vohra et al. · 2025 · British Journal of Dermatology
  49. Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies
    Stephanie Ji, Hao Liu, Laura A. Pachella, Ryan D. Stephenson, Roman Groisberg, Sarah Ann Weiss · 2023 · Frontiers in Transplantation
  50. IMPDH inhibition induces DNA replication stress and ATR sensitivity in Merkel cell carcinoma
    Julia L. Schnabel, Thomas C. Frost, Adam C. Wang, Varsha Ananthapadmanabhan, Satvik Gurram, Kara M. Soroko, Prafulla C. Gokhale, James A. DeCaprio · 2025 · iScience
  51. IFN γ and the IFN γ Signaling Pathways in Merkel Cell Carcinoma
    Lina Song, Jinye Guan, Qunmei Zhou, Wenshang Liu, Jürgen Christian Becker, Dan Deng · 2025 · Cancers
  52. Merkel cell carcinoma of the head and neck in the south-east of England
    Conor M. Bowe, T. Bean, R Loke, N. Gallagher, Joan Rooney, Christian Surwald, Jagtar Dhanda, A.B. Moody, Brian Bisase, Paul M. Norris et al. · 2021 · British Journal of Oral and Maxillofacial Surgery
  53. Merkel Cell Carcinoma of the External Ear: Population-Based Analysis and Survival Outcomes
    André S. Alves, Matteo Scampa, Jérôme Martineau, Salvatore A. Giordano, Daniel Felix Kalbermatten, Carlo Maria Oranges · 2022 · Cancers
  54. Targeted therapy and immunotherapy for orbital and periorbital tumors: a major review
    Emmanuel Lee Boniao, Richard C. Allen, Gangadhara Sundar · 2023 · Orbit
  55. Circulating tumor DNA serial monitoring of relapse and responses to tislelizumab immunotherapy as second‑line monotherapy for metastatic esophageal squamous cell carcinoma: A prospective study
    Qiong He, Xun Shi, Junrong Yan, Mengmeng Wu, Cuiping Gu, Xinmin Yu · 2024 · Molecular and Clinical Oncology
  56. Clinical treatment strategy and follow-up of lymphoepithelioma-like carcinoma: a retrospective study
    Shilong Zhang, Yufu Lin, Zhiyong Li, Zhiming Wang, Rongkui Luo, Xiuping Zhang · 2024 · Future Science OA
  57. Biomarqueurs prédictifs de l’efficacité des inhibiteurs de checkpoint immunitaire dans le traitement des cancers
    M. Duruisseaux, Cécile Lize-Dufranc, Cécile Badoual, Frédéric Bibeau · 2017 · Annales de Pathologie
  58. Activation of Protein Kinase C ε in Merkel Cell Polyomavirus–Induced Merkel Cell Carcinoma
    ADILSON VIDAL COSTA, Jamie B. MacKelfresh, Linda C. Gilbert, Michael Yi Bonner, Jack L. Arbiser · 2017 · JAMA Dermatology
  59. In‐transit recurrence of Merkel cell carcinoma associated with Bowen's disease: The first reported case successfully treated by avelumab
    Takahiro Kiyohara, Takako Shijimaya, Mari Miyamoto, Naoko Nagano, Sei Nakamaru, Kaoru Makimura, Hirotsugu Tanimura · 2019 · The Journal of Dermatology
  60. Heart Block Caused by Cardiac Metastasis From Merkel Cell Carcinoma: A Case Report
    Nazanin Yeganeh Kazemi, Christopher Charles Jain, Melanie C. Bois, Atta Behfar, Kenneth R. Olivier, Svetomir N. Markovic · 2019 · Mayo Clinic Proceedings Innovations Quality & Outcomes
  61. Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment
    Shota Aoyama, Ryosuke Nakagawa, Satoshi Nemoto, Patricio Perez-Villarroel, James J. Mulé, Adam William Mailloux · 2021 · Journal for ImmunoTherapy of Cancer
  62. Place de la radiothérapie dans le traitement des carcinomes cutanés
    L. Quéro, Ingrid Fumagalli, Bethsabée Benadon, Fabien Mignot, S. Haberer-Guillerm, Mouna Labidi, Christophe Hennequin · 2021 · Cancer/Radiothérapie
  63. An update on local and systemic therapies for nonmelanoma skin cancer
    Kelly M. Elleson, Danielle K. DePalo, Jonathan S. Zager · 2022 · Expert Review of Anticancer Therapy
  64. Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
    Paolo A. Ascierto, Antonio Avallone, Nina Bhardwaj, Carlo Bruno Bifulco, Sergio Bracarda A, Joshua Brody, Luigi Buonaguro, Sandra Demaria, Leisha A. Emens, Robert Louis Ferris et al. · 2022 · Journal of Translational Medicine
  65. The Role of Pathology-Based Methods in Qualitative and Quantitative Approaches to Cancer Immunotherapy
    Olga Kuczkiewicz‐Siemion, Kamil Sokół, Beata Puton, Aneta Maria Borkowska, Anna Szumera‐Ciećkiewicz · 2022 · Cancers
  66. Dietary Considerations for Inflammatory Bowel Disease Are Useful for Treatment of Checkpoint Inhibitor-Induced Colitis
    Aditi Saha, Isabella Dreyfuss, Humaira Rise Sarfraz, Mark Friedman, Joseph Markowitz · 2022 · Cancers
  67. The non-T-cell-inflamed tumor microenvironment: contributing factors and therapeutic solutions
    Brendan L. Horton, Stefani Spranger · 2017 · Emerging Topics in Life Sciences
  68. PD-L1 and Other Immunological Diagnosis Tools
    Nicolás A. Giraldo, Janis Marie Taube · 2017 · Springer eBooks
  69. Merkel cell carcinoma of the thigh: case report and review of the literature
    Wen Hui Jiang, Jiali Xu, Rong Wang, Tingting Wang, Yongqian Shu, Lianke Liu · 2019 · OncoTargets and Therapy
  70. An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report
    Alexander Dean Sherry, Michael Bezzerides, Mohamed H. Khattab, Guozhen Luo, Kristin Kathleen Ancell, Austin Noah Kirschner · 2020 · Strahlentherapie und Onkologie
  71. Merkel Cell Polyomavirus and Human Merkel Cell Carcinoma
    Wei Liu, Jianxin You · 2020 · Recent results in cancer research/Recent Results in Cancer Research
  72. Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy
    Ying Zheng, Ting Yu, Rachel H. Mackey, Julie A Gayle, Christina L. Wassel, Hemant M. Phatak, Ruth Kim · 2021 · ClinicoEconomics and Outcomes Research
  73. Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally
    Andrew C. Esposito, Daniel Jacobs, Stephan Ariyan, Anjela Galan, Harriet M. Kluger, James E. Clune, Sarah Ann Weiss, Thuy Thanh Thi Tran, Kelly L. Olino · 2021 · Annals of Surgical Oncology
  74. Sudden and severe cardiotoxicity induced with pembrolizumab, its clinical course, therapeutic intervention, and outcome
    Tomohiro Matsumoto, Koji Fukuda, Taichi Yoshida, Kazuhiro Shimazu, Daiki Taguchi, Hanae Shinozaki, Katsuhito Seki, Takayuki Yamanaka, Mako Ootaka, Hiroshi Nanjyo et al. · 2021 · International Cancer Conference Journal
  75. Advances in Immunology: A Cornerstone in Diagnosis and Therapy of Merkel Cell Carcinoma
    Wyatt Lydolph, Sai Prasad Desikan, Shiyu Wang, John Allgood, Charles McClains, Jennifer Mclaughlin, Raman K. Desikan · 2022 · Journal of Investigative Medicine High Impact Case Reports
  76. Expert recommendation on diagnostic-therapeutic management in skin carcinomas
    Piotr Lukasz Rutkowski, Witold Owczarek, Dariusz Nejc, Arkadiusz Jeziorski, Wojciech Maria Wysocki, Monika Słowińska, Monika Dudzisz‐Śledź, Piotr Wiśniewski, Hanna Tchórzewska-Korba, Anna Szumera‐Ciećkiewicz et al. · 2022 · Oncology in Clinical Practice
  77. Merkel cell carcinoma: cutaneous manifestation of a highly malignant pre-/pro-B cell neoplasia?
    Christopher Martin Sauer, Emil Chteinberg, Dorit Rennspiess, Anna Kordelia Kurz, Axel zur Hausen · 2017 · RWTH Publications (RWTH Aachen)
  78. A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma
    Daniele Lavacchi, Stefania Nobili, Marco Brugia, Agnese Paderi, Sara Fancelli, Enrico Caliman, Federica Vergoni, Enrico Mini · 2018 · BMC Cancer
  79. Management of Regional Lymph Nodes in Patients with Merkel Cell Carcinoma Following a Positive Sentinel Node Biopsy: Less May be More, But is Either Enough?
    George Hruby, Alexander David Guminski, John F. Thompson · 2018 · Annals of Surgical Oncology
  80. 1045 High dimensional profiling of merkel cell polyomavirus-specific T cells in response to anti-PD-1 immunotherapy
    Heeju Ryu, Timothy Bi, Korok Sarkar, Candice D. Church, Nirasha Ramchurren, Thomas Pulliam, Steven P. Fling, Paul Nghiem, Evan William Newell · 2022 · Journal for ImmunoTherapy of Cancer
  81. YouTube as a source of information on Merkel cell carcinoma
    Abdullah Evren Yetişir · 2023 · TURKDERM
  82. A hybrid machine learning approach for the personalized prognostication of aggressive skin cancers
    Tom William Andrew, Mogdad F. Alrawi, Ruth Plummer, Nick J. Reynolds, V K Sondak, Isaac Brownell, Penny E. Lovat, Aidan Rose, Sophia Z. Shalhout · 2025 · npj Digital Medicine
  83. Is the Addition of Chemotherapy to Adjuvant Radiation in Merkel Cell Cancer Beneficial? Real-World Data with Long-Term Follow-Up
    Walid Shalata, Hanna T. Frumin Edri, Ina Sarel, Anna Ievko, Sofiia Turaieva, T. N. Tairov, Ilia Berezhnov, Shlomit Fenig, Eyal Fenig, Tomer Ziv‐Baran et al. · 2025 · Cancers
  84. CD200R blockade enhances anti-tumor immunity by unleashing NK and CD8+ T cells in tumor
    Zhengfeng Zhang, Yu Zhang, Ya–Wen Chen, Guoshuai Cao, Xiaodong Zheng, Rui Sun, Hui Peng, Zhigang Tian, Haoyu Sun · 2025 · Acta Pharmacologica Sinica
  85. Prediction of Cardiac Arrhythmias in Cancer Patients Treated with Immune Checkpoint Inhibitors Using Electrocardiogram
    Alper Coşkun, Ece Çelebi Coşkun, Ahmet Bilgehan Şahin, Fatih Levent, Eyüp Çoban, Fatih Koca, Seda Sali, Ömer Furkan Demir, Adem Deligönül, Erhan Tenekecioğlu et al. · 2025 · Diagnostics
  86. Current Trends in Clinical Trials for Merkel Cell Carcinoma (MCC)
    Tilak Patel, Rachel Butz, Brian C. Boulmay, Vilija J. Vaitaitis · 2025 · Cancers
  87. Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade
    Lisa May Ling Tachiki, Yasman Moshiri, Daniel S. Hippe, Emily Gong, Lauren Zawacki, Thomas Pulliam, Kristina Lachance, Candice D. Church, Alex Fu, Emily Huynh et al. · 2025 · Journal for ImmunoTherapy of Cancer
  88. Polyomavirus Antibodies for Merkel Cell Carcinoma Recurrence Detection
    Lindsay Gunnell, Daniel S. Hippe, Song Youn Park, Alex Fu, Tomoko Akaike, Kristina Lachance, Kelsey Cahill, Coley Doolittle‐Amieva, Paul Nghiem · 2025 · JAMA Dermatology
  89. Molecular Characterization of Polyomavirus-Positive and Negative Merkel Cell Carcinoma
    Poorva Vaidya, Sharon K. Wu, Dave Bryant, Curtis J. Perry, Varsha Prakash, Emil Lou, Theresa W. Guo, Isaac Brownell, Sourat Darabi, Ling Gao et al. · 2025 · Cancers
  90. Head and Neck Merkel Cell Carcinoma: A 12-Year Single Institutional Experience
    Ciarán Hurley, Daniah ALNafisee, Dyna Jones, J.L. Kelly, P.J. Regan, A. J. Hussey, Niall M. McInerney · 2022 · JPRAS Open
  91. Review of Merkel cell carcinoma with solitary pancreatic metastases mimicking primary neuroendocrine tumor of the pancreas
    Akriti Pokhrel, Richard Wu, Jen Chin C. Wang · 2023 · Clinical Journal of Gastroenterology
  92. Merkel cell carcinoma and the eye
    Rodolfo Valentini, Jane Margaret Grant-Kels, Madina Falcone, Campbell L. Stewart · 2024 · Clinics in Dermatology
  93. Profound ctDNA and radiological responses after 2 cycles of avelumab in a metastatic Merkel cell carcinoma of the head and neck
    Santiago Cabezas-Camarero, Pedro Pérez‐Segura, Alejandro Riquelme, Javier Román-García · 2024 · Oral Oncology
  94. Immune check point inhibitors for ocular adnexal and periocular tumors
    Palwasha Syar, Sara Moussavi, Carlos Torres-Caballa, Bita Esmaeli · 2025 · Taiwan Journal of Ophthalmology
  95. Primary Visceral Merkel Cell Carcinoma: A Case Report and Review of the Literature
    Andrew B. Siref, Andrew Eugene Hendifar, Bonnie Lei Balzer · 2018 · American Journal of Dermatopathology
  96. Anti‐ PD 1 in Merkel cell carcinoma and cutaneous squamous cell carcinoma, description of five cases and recent data from the literature
    D. Sellah, Mélanie Saint-Jean, L. Peuvrel, Amir Khammari, Gaelle Quereux, Brigitte Dréno · 2018 · Journal of the European Academy of Dermatology and Venereology
  97. Un tour d’horizon du développement de biomarqueurs pour les anticorps PD-1 et PD-L1 en cancérologie
    Lisa Chaput, Lars Petter Jordheim · 2021 · Therapies
  98. Merkel cell carcinoma brain metastasis with radiological findings mimicking primary CNS lymphoma: illustrative case
    Siyuan Yu, Craig Schreiber, Rahul Garg, Ashleigh Allen, Alan R. Turtz · 2022 · Journal of Neurosurgery Case Lessons
  99. Facial Merkel cell carcinoma in a patient with diabetes and hepatitis B: A case report
    Ming-Yang Ren, Yun-Juan Shi, Wei Lu, Shasha Fan, Xiaohua Tao, Yang Ding · 2023 · World Journal of Clinical Cases
  100. Sentinel lymph node biopsy in periocular merkel cell carcinoma: a case report
    Dan C. Filitis, György Paragh, Faramarz H. Samie, Nathalie C. Zeitouni · 2017 · BMC Research Notes